Lipid Metabolism and Cancer Immunotherapy: Immunosuppressive Myeloid Cells at the Crossroad

Lipid Metabolism and Cancer Immunotherapy: Immunosuppressive Myeloid Cells at the Crossroad

Cancer progression generates a chronic inflammatory state that dramatically influences hematopoiesis, originating different subsets of immune cells that can exert pro- or anti-tumor roles. Commitment towards one of these opposing phenotypes is driven by inflammatory and metabolic stimuli derived fro...

Full description

Bibliographic Details
Main Authors:	Augusto Bleve, Barbara Durante, Antonio Sica, Francesca Maria Consonni
Format:	Article
Language:	English
Published:	MDPI AG 2020-08-01
Series:	International Journal of Molecular Sciences
Subjects:	tumor-associated macrophages (TAMs) myeloid-derived suppressor cells (MDSCs) cancer immunotherapy lipid metabolism obesity fatty acids
Online Access:	https://www.mdpi.com/1422-0067/21/16/5845

Similar Items

Evolution and Targeting of Myeloid Suppressor Cells in Cancer: A Translational Perspective
by: Augusto Bleve, et al.
Published: (2022-01-01)

Emerging strategies in targeting tumor-resident myeloid cells for cancer immunotherapy
by: Yi Wang, et al.
Published: (2022-08-01)

Myeloid-Derived Suppressor Cells: Ductile Targets in Disease
by: Francesca Maria Consonni, et al.
Published: (2019-05-01)

Tasquinimod targets suppressive myeloid cells in the tumor microenvironment
by: Li Shen, et al.
Published: (2019-10-01)

Editorial: NK-Myeloid Cell Interactions in the Tumor Microenvironment: Implications for Cancer Immunotherapy
by: Erik Wennerberg, et al.
Published: (2021-07-01)

Fatty Acid Metabolism in Myeloid-Derived Suppressor Cells and Tumor-Associated Macrophages: Key Factor in Cancer Immune Evasion
by: Sophiya Siddiqui, et al.
Published: (2022-01-01)

Roles of Myeloid-Derived Suppressor Cell Subpopulations in Autoimmune Arthritis
by: Min Li, et al.
Published: (2018-12-01)

Myeloid-Derived Suppressor Cells in Solid Tumors
by: Tianmiao Ma, et al.
Published: (2022-01-01)

Myeloid-Derived Suppressor Cells (MDSCs) in Ovarian Cancer—Looking Back and Forward
by: Karolina Okła
Published: (2023-07-01)

Local and Systemic Injections of Human Cord Blood Myeloid-Derived Suppressor Cells to Prevent Graft Rejection in Corneal Transplantation
by: Jae-young Lee, et al.
Published: (2022-12-01)

MDSC in Mice and Men: Mechanisms of Immunosuppression in Cancer
by: Christophe Vanhaver, et al.
Published: (2021-06-01)

Myeloid-derived suppressor cells and vaccination against pathogens
by: Estefanía Prochetto, et al.
Published: (2022-09-01)

Suppressing MDSC Recruitment to the Tumor Microenvironment by Antagonizing CXCR2 to Enhance the Efficacy of Immunotherapy
by: Kennady Bullock, et al.
Published: (2021-12-01)

Landscape of Myeloid-derived Suppressor Cell in Tumor Immunotherapy
by: Zhaonian Hao, et al.
Published: (2021-10-01)

The role of myeloid-derived suppressor cells in the pathogenesis of rheumatoid arthritis; anti- or pro-inflammatory cells?
by: Misagh Rajabinejad, et al.
Published: (2019-12-01)

Monocytic myeloid-derived suppressor cells as an immune indicator of early diagnosis and prognosis in patients with sepsis
by: Juanjuan Cui, et al.
Published: (2024-04-01)

Identification and validation of Birc5 as a novel activated cell cycle program biomarker associated with infiltration of immunosuppressive myeloid‐derived suppressor cells in hepatocellular carcinoma
by: Yun Liu, et al.
Published: (2023-08-01)

Targeting of immunosuppressive myeloid cells from glioblastoma patients by modulation of size and surface charge of lipid nanocapsules
by: Laura Pinton, et al.
Published: (2020-02-01)

Myeloid Cells as Clinical Biomarkers for Immune Checkpoint Blockade
by: Elisa Peranzoni, et al.
Published: (2020-07-01)

Lipid Metabolic Pathways Confer the Immunosuppressive Function of Myeloid-Derived Suppressor Cells in Tumor
by: Dehong Yan, et al.
Published: (2019-06-01)

Metabolic Regulation of Myeloid-Derived Suppressor Cell Function in Cancer
by: Yufei Wang, et al.
Published: (2020-04-01)

Toll-like receptor 2 ligand and interferon-γ suppress anti-tumor T cell responses by enhancing the immunosuppressive activity of monocytic myeloid-derived suppressor cells
by: Hiroaki Shime, et al.
Published: (2018-01-01)

VLA-1 Binding to Collagen IV Controls Effector T Cell Suppression by Myeloid-Derived Suppressor Cells in the Splenic Red Pulp
by: Ina N. Eckert, et al.
Published: (2021-01-01)

Role of Polymorphonuclear Myeloid‐Derived Suppressor Cells and Neutrophils in Ischemic Stroke
by: Haomin Yan, et al.
Published: (2023-03-01)

Pivotal role of myeloid‐derived suppressor cells in infection‐related tumor growth
by: Nozomi Ito, et al.
Published: (2024-02-01)

TGF-β Enhances Immunosuppression of Myeloid-Derived Suppressor Cells to Induce Transplant Immune Tolerance Through Affecting Arg-1 Expression
by: Peng Cao, et al.
Published: (2022-07-01)

Allies or Enemies—The Multifaceted Role of Myeloid Cells in the Tumor Microenvironment
by: Lisa Haas, et al.
Published: (2019-11-01)

Altered Metabolism in Glioblastoma: Myeloid-Derived Suppressor Cell (MDSC) Fitness and Tumor-Infiltrating Lymphocyte (TIL) Dysfunction
by: Natalia Di Ianni, et al.
Published: (2021-04-01)

A Proteomic Atlas of Lineage and Cancer-Polarized Expression Modules in Myeloid Cells Modeling Immunosuppressive Tumor-Infiltrating Subsets
by: Ester Blanco, et al.
Published: (2021-06-01)

Novel Paired Cell Lines for the Study of Lipid Metabolism and Cancer Stemness of Hepatocellular Carcinoma
by: Yun-Hsin Cheng, et al.
Published: (2022-05-01)

TIGIT and PD-1 Immune Checkpoint Pathways Are Associated With Patient Outcome and Anti-Tumor Immunity in Glioblastoma
by: Itay Raphael, et al.
Published: (2021-05-01)

Immunosuppressive Activity of Exosomes from Granulocytic Myeloid-Derived Suppressor Cells in a Murine Model of Immune Bone Marrow Failure
by: Ash Lee Manley, et al.
Published: (2023-09-01)

Ablation of NLRP3 inflammasome rewires MDSC function and promotes tumor regression
by: Iosif Papafragkos, et al.
Published: (2022-08-01)

Short-chain fatty acids ameliorate allergic airway inflammation via sequential induction of PMN-MDSCs and Treg cells
by: Min-Ting Huang, MSc, et al.
Published: (2023-11-01)

Immunosuppressive Effects of Myeloid-Derived Suppressor Cells in Cancer and Immunotherapy
by: Mithunah Krishnamoorthy, et al.
Published: (2021-05-01)

Obesity-Associated Myeloid-Derived Suppressor Cells Promote Apoptosis of Tumor-Infiltrating CD8 T Cells and Immunotherapy Resistance in Breast Cancer
by: Justin T. Gibson, et al.
Published: (2020-10-01)

Current perspectives on the immunosuppressive tumor microenvironment in hepatocellular carcinoma: challenges and opportunities
by: Chen Lu, et al.
Published: (2019-08-01)

Inflammation and Myeloid Cells in Cancer Progression and Metastasis
by: Jenying Deng, et al.
Published: (2022-01-01)

Significance of Immunosuppressive Cells as a Target for Immunotherapies in Melanoma and Non-Melanoma Skin Cancers
by: Taku Fujimura, et al.
Published: (2020-07-01)

Differential regulation of myeloid-derived suppressor cells by Candida species
by: Anurag Singh, et al.
Published: (2016-10-01)